Ebola — Precision Vaccinations

Fact checked by Robert Carlson, MD

Apr 18

3 min read

Ebola Virus Shedding Reported in 30% of Male Survivors

PREVAIL III clinical trial reported Ebola RNA was detected in 30 percent of male semen samples up to 40 months from time of illness

microscope

Category:

Fact checked by Robert Carlson, MD

Apr 14

3 min read

Ebola Zaire Vaccine Candidate Scores an A+

Merck v920 (rVSV-ZEBOV-GP) Ebola vaccine candidate reported 97.5 percent effective

cheering african people for the Merck ebola drug

Category:

Fact checked by Kelley Lu, PharmD

Apr 10

3 min read

UTMB to Combat Filoviruses With $35 Million Grant

Ebola and Marburg are Tier 1 pathogens without approved vaccines or broad-spectrum treatments

medical lab researchers

Category:

Fact checked by Robert Carlson, MD

Apr 9

4 min read

Rwanda Launches Ebola Vaccination Campaign for 7,949 Workers

Ebola vaccine V920 (rVSV-ZEBOV) to be deployed in Rwanda

map of central africa

Category:

Fact checked by Robert Carlson, MD

Apr 1

3 min read

Remdesivir to Treat Ebola Virus Infections

Remdesivir (GS-5734) is rapidly progressing in the study pipeline

young african boy smiling

Category: